Presentation is loading. Please wait.

Presentation is loading. Please wait.

Carrie C. Lubitz, Sareh Parangi, Tammy M. Holm, M

Published byBeryl Charles Modified over 5 years ago

Similar presentations

Presentation on theme: "Carrie C. Lubitz, Sareh Parangi, Tammy M. Holm, M"— Presentation transcript:

1 Detection of Circulating BRAFV600E in Patients with Papillary Thyroid Carcinoma 
Carrie C. Lubitz, Sareh Parangi, Tammy M. Holm, M. Jordana Bernasconi, Aislyn P. Schalck, Hyunsuk Suh, Konstantinos P. Economopoulos, Viswanath Gunda, Samuel E. Donovan, Peter M. Sadow, Lori J. Wirth, Ryan J. Sullivan, David J. Panka  The Journal of Molecular Diagnostics  Volume 18, Issue 1, Pages (January 2016) DOI: /j.jmoldx Copyright © 2016 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

2 Figure 1 A: Schematic of the BRAFV600E assay. B: Standard curve of the BRAF assay used for quantification. The equation representative of the best fit line for the BRAFV600E (lower equation) and the wild-type (WT) BRAF (upper equation) are shown. Experiments were used to calculate the standard deviations of the a375 (BRAFV600E hemizygous cell line) and 786 (BRAF wild-type cell line), respectively. n = 5 and 3 experiments. Panel A was reproduced from Panka et al25 with permission from American Association for Cancer Research. The Journal of Molecular Diagnostics  , DOI: ( /j.jmoldx ) Copyright © 2016 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

3 Figure 2 Receiver-operating analysis with each of the 70 circulating BRAFV600E levels as a possible positivity criterion in predicting the gold standard (tissue BRAF testing). AUC, area under the curve. The Journal of Molecular Diagnostics  , DOI: ( /j.jmoldx ) Copyright © 2016 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

4 Figure 3 Circulating levels of BRAFV600E by pathologic diagnosis (benign, left; malignant, right) and tissue mutational status. Benign/BRAF− indicates a tumor that was read as either an adenoma or a benign hyperplastic lesion that is also negative for BRAFV600E by conventional tissue testing. Benign/BRAF+ indicates pathologically negative, tissue BRAFV600E+. Asterisk indicates patients with known distant metastatic disease. The Journal of Molecular Diagnostics  , DOI: ( /j.jmoldx ) Copyright © 2016 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Download ppt "Carrie C. Lubitz, Sareh Parangi, Tammy M. Holm, M"

Similar presentations

Functional Analysis of the Neurofibromatosis Type 2 Protein by Means of Disease- Causing Point Mutations Renee P. Stokowski, David R. Cox The American.

Functional Analysis of the Neurofibromatosis Type 2 Protein by Means of Disease- Causing Point Mutations Renee P. Stokowski, David R. Cox The American.
Measurement of Relative Copy Number of CDKN2A/ARF and CDKN2B in Bladder Cancer by Real-Time Quantitative PCR and Multiplex Ligation-Dependent Probe Amplification.

Measurement of Relative Copy Number of CDKN2A/ARF and CDKN2B in Bladder Cancer by Real-Time Quantitative PCR and Multiplex Ligation-Dependent Probe Amplification.
CyclinD1/CyclinD3 Ratio by Real-Time PCR Improves Specificity for the Diagnosis of Mantle Cell Lymphoma Carol D. Jones, Katherine H. Darnell, Roger A.

CyclinD1/CyclinD3 Ratio by Real-Time PCR Improves Specificity for the Diagnosis of Mantle Cell Lymphoma Carol D. Jones, Katherine H. Darnell, Roger A.
Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival Ryan K. Van Laar The.

Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival Ryan K. Van Laar The.
PITX2 DNA Methylation as Biomarker for Individualized Risk Assessment of Prostate Cancer in Core Biopsies  Barbara Uhl, Heidrun Gevensleben, Yuri Tolkach,

PITX2 DNA Methylation as Biomarker for Individualized Risk Assessment of Prostate Cancer in Core Biopsies  Barbara Uhl, Heidrun Gevensleben, Yuri Tolkach,
KRAS and BRAF Mutation Analysis in Routine Molecular Diagnostics

KRAS and BRAF Mutation Analysis in Routine Molecular Diagnostics
The Use of COLD-PCR and High-Resolution Melting Analysis Improves the Limit of Detection of KRAS and BRAF Mutations in Colorectal Cancer  Irene Mancini,

The Use of COLD-PCR and High-Resolution Melting Analysis Improves the Limit of Detection of KRAS and BRAF Mutations in Colorectal Cancer  Irene Mancini,
Statistical Considerations for Immunohistochemistry Panel Development after Gene Expression Profiling of Human Cancers  Rebecca A. Betensky, Catherine.

Statistical Considerations for Immunohistochemistry Panel Development after Gene Expression Profiling of Human Cancers  Rebecca A. Betensky, Catherine.
High-Throughput Homogeneous Mass Cleave Assay Technology for the Diagnosis of Autosomal Recessive Parkinson's Disease  Christopher Schroeder, Michael.

High-Throughput Homogeneous Mass Cleave Assay Technology for the Diagnosis of Autosomal Recessive Parkinson's Disease  Christopher Schroeder, Michael.
Evaluation of the Real-Q BRAF V600E Detection Assay in Fine-Needle Aspiration Samples of Thyroid Nodules  Kyung Sun Park, Young L. Oh, Chang-Seok Ki,

Evaluation of the Real-Q BRAF V600E Detection Assay in Fine-Needle Aspiration Samples of Thyroid Nodules  Kyung Sun Park, Young L. Oh, Chang-Seok Ki,
KRAS and BRAF Mutation Analysis in Routine Molecular Diagnostics

KRAS and BRAF Mutation Analysis in Routine Molecular Diagnostics
Single-Color Digital PCR Provides High-Performance Detection of Cancer Mutations from Circulating DNA  Christina Wood-Bouwens, Billy T. Lau, Christine.

Single-Color Digital PCR Provides High-Performance Detection of Cancer Mutations from Circulating DNA  Christina Wood-Bouwens, Billy T. Lau, Christine.
Laboratory Guidelines for Detection, Interpretation, and Reporting of Maternal Cell Contamination in Prenatal Analyses  Narasimhan Nagan, Nicole E. Faulkner,

Laboratory Guidelines for Detection, Interpretation, and Reporting of Maternal Cell Contamination in Prenatal Analyses  Narasimhan Nagan, Nicole E. Faulkner,
Next-Generation Sequencing

Next-Generation Sequencing
A Quantitative Allele-Specific PCR Test for the BRAF V600E Mutation Using a Single Heterozygous Control Plasmid for Quantitation  Philippe Szankasi, N.

A Quantitative Allele-Specific PCR Test for the BRAF V600E Mutation Using a Single Heterozygous Control Plasmid for Quantitation  Philippe Szankasi, N.
Detection of Mismatch Repair Deficiency and Microsatellite Instability in Colorectal Adenocarcinoma by Targeted Next-Generation Sequencing  Jonathan A.

Detection of Mismatch Repair Deficiency and Microsatellite Instability in Colorectal Adenocarcinoma by Targeted Next-Generation Sequencing  Jonathan A.
Cystic Fibrosis The Journal of Molecular Diagnostics

Cystic Fibrosis The Journal of Molecular Diagnostics
Multiplex Preamplification of Serum DNA to Facilitate Reliable Detection of Extremely Rare Cancer Mutations in Circulating DNA by Digital PCR  Jennifer.

Multiplex Preamplification of Serum DNA to Facilitate Reliable Detection of Extremely Rare Cancer Mutations in Circulating DNA by Digital PCR  Jennifer.
A Multiplex SNaPshot Assay as a Rapid Method for Detecting KRAS and BRAF Mutations in Advanced Colorectal Cancers  Sandrine Magnin, Erika Viel, Alice.

A Multiplex SNaPshot Assay as a Rapid Method for Detecting KRAS and BRAF Mutations in Advanced Colorectal Cancers  Sandrine Magnin, Erika Viel, Alice.
Development and Validation of a Preanalytic Procedure for Performing the cobas HPV Test in SurePath Preservative Fluid  Mark D. Krevolin, David Hardy,

Development and Validation of a Preanalytic Procedure for Performing the cobas HPV Test in SurePath Preservative Fluid  Mark D. Krevolin, David Hardy,

Similar presentations

Ads by Google